Details for New Drug Application (NDA): 074368
✉ Email this page to a colleague
The generic ingredient in NADOLOL is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.
Summary for 074368
Tradename: | NADOLOL |
Applicant: | Teva Pharms |
Ingredient: | nadolol |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 074368
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 80MG | ||||
Approval Date: | Aug 31, 1994 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 120MG | ||||
Approval Date: | Aug 31, 1994 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 160MG | ||||
Approval Date: | Aug 31, 1994 | TE: | RLD: | No |
Complete Access Available with Subscription